Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for myocardial protection during mitral valve surgery
IRCT20210710051837N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in mitral valve disease comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Troponin I change and Creatine kinase-MB change. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
mitral valve disease
Beyond the preview
Go deeper on IRCT20210710051837N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210710051837N1.